4.7 Article

SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function

Journal

EMBO MOLECULAR MEDICINE
Volume 13, Issue 2, Pages -

Publisher

WILEY
DOI: 10.15252/emmm.202012632

Keywords

glycine transporter; neuropsychiatric disorders; NMDA receptor; PTEN; Slc6a20

Funding

  1. National Research Foundation of Korea [NRF-2017R1A5A2015391, NRF-2017R1A2B3002862, NRF-2019R1C1C1010482, NRF-2017M3C7A1079692]
  2. Korea Institute of Science and Technology Information [K-18-L12-C08-S01]
  3. Institute for Basic Science [IBS-R002-A1, IBS-R002-D1]
  4. Ministry of Science & ICT (MSIT), Republic of Korea [IBS-R002-D1-2021-A00, K-18-L12-C08] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  5. National Research Foundation of Korea [2017M3C7A1079692] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Research has shown that SLC6A20A is an amino acid transporter that regulates proline and glycine balance in the brain and NMDAR function. Mutant PTEN protein may enhance abnormal expression of SLC6A20A transcript and protein by increasing binding to the Slc6a20a gene. Modulating SLC6A20A can normalize NMDAR currents and restore behavior in mice.
Glycine transporters (GlyT1 and GlyT2) that regulate levels of brain glycine, an inhibitory neurotransmitter with co-agonist activity for NMDA receptors (NMDARs), have been considered to be important targets for the treatment of brain disorders with suppressed NMDAR function such as schizophrenia. However, it remains unclear whether other amino acid transporters expressed in the brain can also regulate brain glycine levels and NMDAR function. Here, we report that SLC6A20A, an amino acid transporter known to transport proline based on in vitro data but is understudied in the brain, regulates proline and glycine levels and NMDAR function in the mouse brain. SLC6A20A transcript and protein levels were abnormally increased in mice carrying a mutant PTEN protein lacking the C terminus through enhanced beta-catenin binding to the Slc6a20a gene. These mice displayed reduced extracellular levels of brain proline and glycine and decreased NMDAR currents. Elevating glycine levels back to normal ranges by antisense oligonucleotide-induced SLC6A20 knockdown, or the competitive GlyT1 antagonist sarcosine, normalized NMDAR currents and repetitive climbing behavior observed in these mice. Conversely, mice lacking SLC6A20A displayed increased extracellular glycine levels and NMDAR currents. Lastly, both mouse and human SLC6A20 proteins mediated proline and glycine transports, and SLC6A20 proteins could be detected in human neurons. These results suggest that SLC6A20 regulates proline and glycine homeostasis in the brain and that SLC6A20 inhibition has therapeutic potential for brain disorders involving NMDAR hypofunction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available